Skip to main content
. 2019 Jan 29;14(1):e0211268. doi: 10.1371/journal.pone.0211268

Fig 10.

Fig 10

Synergistic combinations between carboplatin and deferoxamine (left), azacytidine-5 (center) and gemcitabine (right) in A549 cells. Dose-dependent increase of QPI/Ho after 72 h of continuous exposure to the drugs alone (in concentrations ranging from ½ x IC50 to 4 x IC50) and their combinations at a fixed concentration ratio. Values are obtained as mean ± SD from 2 wells/condition and 9 field of view/well.